Welcome to Cancerland with David Scadden, MD

Thursday, June 20, 2019

Episode 22:

David Scadden, MD, of Harvard University Medical School, Boston, joins Blood & Cancer host David H. Henry, MD, of the University of Pennsylvania, Philadelphia, for a conversation about his book, “Cancerland: A Medical Memoir,” as well as immunotherapy and the challenge of patient care in the EHR age.

Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University talks about enrolling patients in clinical trials and the tension between their needs and the goals of research.

Read more about Dr. Scadden’s research: http://www.scaddenlab.com/

Read more about Cancerland: https://us.macmillan.com/books/9781250092755

For more MDedge Podcasts, go to mdedge.com/podcasts

Email the show: podcasts@mdedge.com

Interact with us on Twitter: @MDedgehemonc

David Henry, MD on Twitter: @davidhenrymd

Ilana Yurkiewicz on Twitter: @ilanayurkiewicz

Podcast Participants

David Henry, MD
David Henry, MD, FACP, is a clinical professor of medicine at the University of Pennsylvania and vice chairman of the department of medicine at Pennsylvania Hospital in Philadelphia. He received his bachelor’s degree from Princeton University and his MD from the University of Pennsylvania, then completed his internship, residency, and fellowship at the Hospital of the University of Pennsylvania. After 2 years as an attending in the U.S. Air Force, he was drawn to practicing as a hem-onc because of the close patient contact and interaction, and his belief that, win or lose with each patient, one can always make a difference in their care and lives. Follow Dr. Henry on Twitter: @davidhenrymd. Dr. Henry reported being on the advisory board for Amgen, AMAG Pharmaceuticals, and Pharmacosmos. He reported institutional funding from the National Institutes of Health and FibroGen.